Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO
July 28 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX: EXPERIENCED CELL THERAPY EXECUTIVE APPOINTED CEO APPOINTS NATHAN SMITH AS CEO Further company coverage: NSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO
Australia's NeuroScientific Biopharmaceuticals soars on buying biotech co